Non classé
Strengthening Global Collaboration: DiCE CEO Visits Mexico to Support FUTEJE
In March, DiCE CEO Zorana Maravic visited Mexico as Special Advisor for the GCCA, collaborating closely with FUTEJE to enhance colorectal cancer pa...
Turning Potential into Action: How Biosimilars Can Reshape Access and Outcomes in Cancer Care
At BIOS25 in Amsterdam, DiCE highlighted patient perspectives on biosimilars. CEO Zorana Maravic underscored the urgent need to overcome barriers, ...
Call for Board Candidates – Help Shape DiCE’s Future!
We’re seeking two dedicated representatives from our Full Member Organisations to shape DiCE’s future strategy and governance. Apply by May 23 ...
DiCE Supports Patient-Led Progress at the Biosimilar Medicines Conference 2025
At BIOS25 in Amsterdam, DiCE joined leading voices to champion patient-centred biosimilar policy. CEO Zorana Maravic called for reinvestment of sav...
DiCE Advocates for Patient-Centred Innovation at CDDF Workshop
DiCE joined experts at the CDDF Workshop to explore breakthroughs in oncology, including targeted therapies and personalised vaccines. We emphasise...
DiCE at the AIDA General Assembly 2025
The AIDA General Assembly 2025 occurred from March 24 to 25 at Imperial College London. It brought together experts, researchers, and consortium me...
ECOPOP Kick-off: Innovating Early Colorectal Cancer Care
On 19–20 March 2025, Digestive Cancers Europe participated in the official kick-off meeting of ECOPOP, a five-year research project funded by Hor...
Why the European Health Data Space (EHDS) Matters for Digestive Cancer Patients
The EHDS can significantly enhance healthcare for digestive cancer patients—but only if patients remain central to its design and implementation....
Collaboration and Progress at EASL Liver Cancer Summit 2025
From the 20th until the 22nd of February, DiCE attended the EASL Liver Cancer Summit in Paris, France. We had several inspiring meetings with repre...
DiCE Helps Shape New Liver Transplant Recommendations for Liver Cancer
Liver transplantation offers new hope for patients with liver cancer. DiCE has played a key role in shaping the most recent recommendations, which ...